Cooperatively assembled signalling complexes, nucleated by adaptor proteins, integrate information from surface receptors to determine cellular outcomes. In T and mast cells, antigen receptor signalling is nucleated by three adaptors: SLP-76, Gads and LAT. Three well-characterized SLP-76 tyrosine phosphorylation sites recruit key components, including a Tec-family tyrosine kinase, Itk. We identified a fourth, evolutionarily conserved SLP-76 phosphorylation site, Y173, which was phosphorylated upon T-cell receptor stimulation in primary murine and Jurkat T cells. Y173 was required for antigen receptorinduced phosphorylation of phospholipase C-c1 (PLC-c1) in both T and mast cells, and for consequent downstream events, including activation of the IL-2 promoter in T cells, and degranulation and IL-6 production in mast cells. In intact cells, Y173 phosphorylation depended on three, ZAP-70-targeted tyrosines at the N-terminus of SLP-76 that recruit and activate Itk, a kinase that selectively phosphorylated Y173 in vitro. These data suggest a sequential mechanism whereby ZAP-70-dependent priming of SLP-76 at three N-terminal sites triggers reciprocal regulatory interactions between Itk and SLP-76, which are ultimately required to couple active Itk to its substrate, PLC-c1.
Introduction
The adaptive immune system responds to antigens through a variety of receptor types, including the T-cell receptor (TCR), B-cell receptor (BCR) and Fc receptors. The latter are indirect antigen receptors whose specificity is determined by the bound antibody. An important example is the FceRI of mast cells, which mediates immediate type hypersensitivity responses upon exposure to the cognate antigen of the bound IgE molecule.
Antigen receptors signal through broadly similar pathways, in which Src-, Syk-and Tec-family tyrosine kinases form a cascade that results in tyrosine phosphorylation and activation of phospholipase C-g isoforms (PLC-g1 or PLC-g2) (Carpenter and Ji, 1999) . In addition to the kinases, cell type specific adaptor proteins are absolutely required for PLC-g phosphorylation. In T cells and mast cells, this function is carried out by a heterotrimeric complex of adaptor proteins consisting of LAT, Gads and SLP-76 (reviewed in Koretzky et al, 2006; Alvarez-Errico et al, 2009; Kambayashi et al, 2009) . LAT is a transmembrane adaptor that is heavily phosphorylated on tyrosine residues upon TCR or FceRI stimulation. PLC-g1 binds directly to LAT, whereas SLP-76 is indirectly recruited to LAT by Gads (Liu et al, 1999; Ishiai et al, 2000) . Within this complex, SLP-76 binds and activates Itk, a Tec-family kinase that can phosphorylate PLC-g1 at the sites required for its activation (Liu et al, 1998; Houtman et al, 2005; Bogin et al, 2007) . In addition, SLP-76 binds to other proteins that regulate PLC-g1 activation by incompletely understood mechanisms; the most prominent among these is Vav (Reynolds et al, 2002) .
Once activated, PLC-g1 produces second messengers, inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol (DAG) , that trigger calcium flux and Ras activation, respectively. In mast cells, increased intracellular calcium triggers rapid release of preformed mediators, through a process of vesicle exocytosis, known as degranulation. These mediators produce most of the symptoms of immediate type hypersensitivity. Over a longer time course, both T and mast cells transcribe and secrete cytokines, through processes that involve calciumcalcineurin-mediated dephosphorylation and activation of the NFAT transcription factor, and Ras-dependent activation of AP-1. As an essential regulator of PLC-g1 activation, the SLP-76 adaptor protein is required for all of the above signalling events (Yablonski et al, 1998; Pivniouk et al, 1999) .
SLP-76 is expressed in all haematopoietic cells except B cells, where an analogous protein, SLP-65/BLNK is expressed (Fu et al, 1998; Wienands et al, 1998) . SLP-76-deficient mice fail to develop mature T cells due to a block in pre-TCR signalling (Clements et al, 1998; Pivniouk et al, 1998) . SLP-76-deficient mast cells develop normally, but exhibit defective responses to FceRI activation (Pivniouk et al, 1999) . In particular, FceRI-induced PLC-g1 activation is defective, as are the ensuing steps of degranulation and cytokine production. In addition, a SLP-76-deficient derivative of the Jurkat T cell line, known as J14, is useful for mechanistic studies of SLP-76. J14 cells fail to activate PLC-g1 or to transcribe IL-2 in response to TCR stimulation, but signalling is restored upon reconstitution with wild-type SLP-76 (Yablonski et al, 1998) . Based on these genetic models, SLP-76 has become an important paradigm for understanding adaptor protein function.
SLP-76 contains three regions that mediate interactions with other signalling proteins: an N-terminal acidic domain that includes three well-characterized tyrosine phosphorylation sites, a central proline-rich domain and a C-terminal SH2 domain . An N-terminal SAM domain is also required for full functionality (Shen et al, 2009) .
Upon TCR stimulation, the three N-terminal tyrosines are phosphorylated by ZAP-70 (Wardenburg et al, 1996; Raab et al, 1997) , and bind to three proteins, Nck, Vav and Itk (Tuosto et al, 1996; Wu et al, 1996; Raab et al, 1997; Bubeck Wardenburg et al, 1998; Su et al, 1999; Wunderlich et al, 1999; Bunnell et al, 2000) . Mutation of all three tyrosines eliminates SLP-76 tyrosine phosphorylation (Fang et al, 1996; Wardenburg et al, 1996) and nearly abrogates its function (Myung et al, 2001; Yablonski et al, 2001; Kettner et al, 2003) .
The central proline-rich domain contains two additional regions that are required for SLP-76 function: a short Gadsbinding motif (Musci et al, 1997; Berry et al, 2002) , and the P-I region, which is found between the N-terminal tyrosine phosphorylation sites and the Gads-binding motif . The P-I region can bind to the SH3 domains of PLC-g1, Itk and Lck (Sanzenbacher et al, 1999; Bunnell et al, 2000; Yablonski et al, 2001; Grasis et al, 2010) ; but its role in T-cell activation has been subject to multiple, often conflicting interpretations (Singer et al, 2004; Gonen et al, 2005; Kumar et al, 2005; Grasis et al, 2010) .
Of the proteins that bind to SLP-76, Itk is the most directly connected to PLC-g1 activation, since it can phosphorylate PLC-g1 at the sites that are required for its activation (Bogin et al, 2007) . Catalytic activation of Itk depends on the inducible interaction of its SH2 domain with the N-terminal tyrosines of SLP-76 (Bogin et al, 2007) . The additional interaction of its SH3 domain with the P-I region of SLP-76 appears to facilitate recruitment of Itk to the immune synapse Grasis et al, 2010 ). An ongoing interaction of SLP-76 with Itk is required to maintain its catalytic activity (Bogin et al, 2007) . This close interaction raises the possibility of reciprocal regulation; whereby SLP-76-activated Itk could feed back onto SLP-76 by phosphorylating it at other sites. Although SLP-76 is considered to have only three tyrosine phosphorylation sites, we suspected that these sites, by recruiting and activating Itk, might prime SLP-76 for phosphorylation at other sites.
In this study, we identified a new tyrosine phosphorylation site on SLP-76 and characterized its importance for antigen receptor signalling in both T cells and mast cells. This new site, Y173, is located in the P-I region of SLP-76, a region that is critical for SLP-76-mediated signalling Singer et al, 2004) , but whose mechanistic role has been difficult to dissect (Gonen et al, 2005) . By revealing an additional layer of regulation in the antigen receptor signalling pathways, this observation brings us closer to understanding the reciprocal interactions between enzymes and adaptor proteins that mediate the rapid and exquisite responsiveness of the immune system.
Results

SLP-76 tyrosine Y173 is selectively phosphorylated by Itk
TCR stimulation triggers a cascade of kinases, each with a distinct role and substrate specificity. The N-terminus of SLP-76 is efficiently phosphorylated by ZAP-70, but not by Src-family kinases (Wardenburg et al, 1996; Raab et al, 1997) . Phosphorylated SLP-76 recruits and activates Itk Bogin et al, 2007) ; in turn, the PLC-g1 sites required for its activation are efficiently phosphorylated by Itk, but not by ZAP-70 (Bogin et al, 2007) . Despite their different substrate specificity, Itk and ZAP-70 exhibited comparable ability to phosphorylate a recombinant SLP-76 substrate in vitro (Lin et al, 2004; Bogin et al, 2007) . This observation prompted us to search for tyrosine phosphorylation sites on SLP-76 that may be selectively phosphorylated by Itk.
To map the sites targeted by each kinase, we immunopurified ZAP-70 and Itk from TCR-stimulated Jurkat cells and tested their ability to phosphorylate recombinant fragments of SLP-76 in vitro. An N-terminal fragment of SLP-76 encompassing residues 2-163 was efficiently phosphorylated by ZAP-70 but not by Itk ( Figure 1A ). Using phosphospecific antisera to SLP-76 Y113, 128 and 145, we detected ZAP-70-mediated phosphorylation of each of these sites (data not shown). This fragment was not phosphorylated by Itk; however, we noted that SLP-76 contains a fourth, evolutionarily conserved tyrosine, located at position 173 (Supplementary Figure S1) . A substrate encompassing this residue was efficiently phosphorylated by Itk, but not by ZAP-70, and phosphorylation was abolished by mutation of Y173 to phenylalanine ( Figure 1B) . These experiments identify Y173 as a potential Itk-targeted phosphorylation site on SLP-76.
TCR-inducible phosphorylation of SLP-76 at Y173 proceeds by a sequential mechanism
We postulated that the efficient phosphorylation of SLP-76 by Itk in vitro may recapitulate what happens upon TCR stimulation of intact cells. To test this idea, we performed mass spectrometric analysis of SLP-76, purified from TCR-stimulated cells. SLP-76 protein was digested with the endoprotease, Asp-N, chosen for its ability to cleave the acidic region of SLP-76, where the known tyrosine phosphorylation sites are found. Phosphorylated peptides were enriched by titanium oxide chromatography followed by MS and MSMS analysis. The expected Asp-N cleavage product, encompassing phosphorylated Y173, was unambiguously detected in this analysis (Figure 2A ). In addition, we detected one of the previously known phosphorylation sites, Y145 (Supplementary Figure S2) .
For routine detection of Y173 phosphorylation, we prepared an affinity-purified, polyclonal, phospho-Y173-specific antiserum. Using this reagent, we observed rapid and transient phosphorylation of Y173 in primary murine thymocytes upon co-crosslinking of CD3 and CD4, whereas CD3 crosslinking was sufficient to induce phosphorylation of Y173 in primary murine splenic T cells ( Figure 2B ).
To confirm the specificity of this reagent, we probed lysates from TCR-stimulated J14 cells, stably reconstituted with FLAG-tagged wild-type or Y173-mutated SLP-76. Wild-type SLP-76 was inducibly phosphorylated at Y173, with a time course roughly parallel to that of the three previously known phosphorylation sites ( Figure 2C , left four lanes). Mutation of Y173 to phenylalanine abolished the signal detected with the phosphoY173 reagent, but did not affect phosphorylation of the three previously known phosphorylation sites ( Figure 2C ). This result provides strong evidence for TCRinducible phosphorylation of Y173. Incidentally, this result also shows that phosphorylation of the three N-terminal sites proceeds independently of Y173.
Phosphorylation of many proteins proceeds according to a stepwise mechanism, whereby one site primes the protein for subsequent phosphorylation at additional sites. In the case of SLP-76, the three N-terminal sites are required for recruitment and activation of Itk (Bogin et al, 2007) , suggesting that they may be required for phosphorylation of Y173. Consistent with this idea, Y173 was not phosphorylated in J14 cells that stably express the Y3F mutant of SLP-76, in which tyrosines 113, 128 and 145 are mutated to phenylalanine ( Figure 3A) .
The N-terminal phosphorylation sites of SLP-76 have been divided into two groups according to the sequence immediately surrounding the phosphorylated tyrosine. Y113 and 128 are embedded in the sequence DYESP, whereas Y145 occurs in the sequence DYEPPP (Fang et al, 1996) . To address their contribution to Y173 phosphorylation, J14 cells were transiently transfected with SLP-76 that was either wild-type or mutated at one (Y145F), two (Y2F; Y113,128F) or three (Y3F; Y113,128,145F) tyrosines. As previously reported (Jordan et al, 2006) , TCR-induced phosphorylation of PLC-g1 was markedly reduced by the single and double mutations of SLP-76 and abrogated by the triple mutation. Phosphorylation of Y173 followed a similar pattern ( Figure 3B ), suggesting that both the DYESP and the DYEPPP motifs contribute to Y173 phosphorylation. Broadly similar results were obtained upon stimulation of thymocytes ( Figure 3C ) or splenic T cells ( Figure 3D ) from gene-targeted mice that bear genomic Y145F or Y112,128F point mutations on SLP-76 (Jordan et al, 2008) . Whereas the Y145F mutation produced a substantial reduction in Y173 phosphorylation, it was virtually eliminated in mice bearing the Y112,128F allele of SLP-76 ( Figure 3C and D). Taken together, these results strongly support TCR-induced sequential phosphorylation of SLP-76 on at least four tyrosines.
Activation of PLC-c1 by the TCR depends on tyrosine 173 of SLP-76
To explore the role of Y173 in TCR signalling, we stably reconstituted J14 cells with wild-type or mutant FLAG-tagged SLP-76, by infection with an IRES-GFP-containing retroviral vector, followed by FACS-based cell sorting to remove noninfected cells. Y173 was disrupted by mutation to phenylalanine (Y173F), to alanine (Y173A) or by a short deletion (D158-180). GFP and TCR expression in each of the cell lines is presented in Supplementary Figure S3 .
We first tested whether Y173 is required for recruitment of proteins to the SLP-76-and LAT-nucleated signalling complex. Upon TCR stimulation, wild-type SLP-76 associated with a number of proteins, including PLC-g1, Vav, Itk, Lck and Nck. None of these interactions was disrupted by the Y173F mutation; however, we reproducibly observed a somewhat extended association of the Y173F mutant with PLC-g1 and Vav ( Figure 4A ). Taken together with Figure 2C , these experiments demonstrate that the Y173F mutation does not affect phosphorylation of SLP-76 at its N-terminal tyrosine phosphorylation sites, nor does it affect the recruitment of Nck, Vav and Itk to these sites. Even the indirect association of SLP-76 with PLC-g1 was not reduced by the Y173F mutation, suggesting that the SLP-76-and LAT-nucleated signalling complex is largely intact.
The overall pattern of TCR-induced tyrosine-phosphorylated proteins was not grossly affected by mutation of Y173; however, phosphorylation of the 150-kDa band corresponding to PLC-g1 was abrogated ( Figure 4B ). The marked dependence of PLC-g1 phosphorylation on tyrosine 173 was more convincingly shown by using a phosphospecific antibody for PLC-g1 Y783, one of the sites required for its activation (Serrano et al, 2005) ( Figure 4C , top two panels). A similar impairment of PLC-g1 phosphorylation was observed upon mutation of Y173 to alanine, or upon deletion of the region of SLP-76 surrounding Y173 (D158-180) (Supplementary Figure S4) . This impairment was quite profound; indeed, PLC-g1 phosphorylation in the Y173F mutant cells was only slightly higher than in the absence of SLP-76 ( Figure 4C ). 6 TCR-stimulated cells, and their catalytic activity was assayed, using the indicated GST-SLP-76 recombinant fusion proteins as in vitro substrates, in the presence or absence of 100 mM ATP. Kinase reaction products were separated by SDS/PAGE, and substrate phosphorylation was detected by probing with anti-phosphotyrosine (4G10) antibody (top panels). The immune complex beads were probed by western blotting with anti-Itk and anti-ZAP-70 antibodies, as indicated (bottom panels). Recombinant substrates were GST alone (À), GST fused to the N-terminal region of SLP-76 (NT; residues 2-163), or GST fused to a fragment of the proline-rich region of SLP-76 (PR; residues 150-196, either wild-type or mutated at Y173). Migration of the NT and PR substrates is indicated with arrows to the right of (B). Results are representative of three independent experiments. See also Supplementary Figure S1 . Unlike the profound decrease in PLC-g1 phosphorylation, TCR-induced tyrosine phosphorylation of Itk did not depend on Y173 of SLP-76 ( Figure 5A ). This result was somewhat surprising since Itk is thought to directly phosphorylate PLC-g1, and we expected that reduced phosphorylation of PLC-g1 might correlate with reduced activation of Itk. To more directly measure Itk kinase activity, we performed an immune complex kinase assay to measure the catalytic activity of Itk, isolated from TCR-stimulated cells that express either wild-type or Y173F SLP-76. This assay was performed using two different recombinant substrates: glutathione Stransferase (GST) fused to a fragment of PLC-g1 that can be phosphorylated by Itk at Y783 (Bogin et al, 2007) , and GST fused to a fragment from the proline-rich region of SLP-76, which can be phosphorylated by Itk at Y173 (see Figure 1B) . Mutation of SLP-76 at Y173 did not reduce activation of Itk, as measured by its ability to phosphorylate either of the exogenous substrates in this assay ( Figure 5B ). Taken together, our results suggest that residue Y173 of SLP-76 is required in the context of intact cells, to couple active Itk to its substrate, PLC-g1.
SLP-76 Y173 is required for signalling events downstream of PLC-c1
PLC-g1 produces two second messengers, IP 3 and DAG, which trigger calcium flux and Ras activation, respectively. TCR-induced calcium flux was reduced in cells expressing SLP-76 Y713F, as compared with cells expressing wild-type SLP-76 ( Figure 6A ). Although the reduction in calcium flux was moderate, it was sustained for at least 1.5 h after TCR stimulation (Supplementary Figure S5) . This ongoing reduction in TCR-induced calcium levels could have a cumulative effect on the ability to mount downstream effector responses. The partial impairment of TCR-induced calcium flux suggests that second messenger production is not completely abrogated by the Y173F mutation. Whereas IP 3 directly triggers calcium release, DAG-mediated activation of the Ras-MAPK pathway proceeds via a positive feedback loop that involves both DAG-dependent activation of Ras-GRP and subsequent activation of a second Ras exchange factor, SOS; 6 cells, and their catalytic activity was assayed. Assay conditions were similar to those used in Figure 1 except that the concentration of ATP was 10 mM, and two different recombinant GST fusion proteins were included in each kinase reaction: GST-PLC-g1 SH2ÀSH2ÀSH3 (Bogin et al, 2007) , and GST fused to residues 150-196 of SLP-76 (SLP-76 PR). Reaction products were separated by SDS-PAGE and probed with anti-phospho-Y783, to detect phosphorylation of GST-PLCg1 SH2ÀSH2ÀSH3 (top panel), 4G10, to detect phosphorylation of the recombinant SLP-76 substrate (middle panel) and anti-Itk, to verify comparable amounts of the kinase in each reaction (bottom panel). wild-type (red) or Y173F-mutated (green) SLP-76 were loaded with indo1-AM and intracellular calcium was measured using a plate fluorimeter as described (Gonen et al, 2005) . Anti-TCR (C305, 1:10 000) was added at 50 s and thapsigargen (1 mM) was added at 410 s. The ratio of emission at 405 nM (calcium-bound indo1) to 486 nm (calcium-free indo1) is presented as a moving average calculated over overlapping 10 s intervals. Results are representative of at least five experiments. See also Supplementary Figure S5. (B) TCR-induced expression of CD69. J14 cells (blue) or cells reconstituted with wild-type SLP-76 (red) or Y173F-mutated SLP-76 (green) were mock stimulated, or stimulated overnight with plate-bound anti-TCR, or with 25 ng/ml of PMA. Cells were surface stained with PE-Cy5-conjugated anti-CD69, and analysed by FACS. Results are representative of three independent experiments. this loop mediates robust activation of the Ras-MAPK pathway in response to even weak signals (Das et al, 2009) . Consistent with this notion, TCR-induced phosphorylation of Erk1 and Erk2 was not reduced by the Y173F mutation ( Figure 4C , bottom two panels); and TCR-induced surface expression of the Ras-dependent activation marker, CD69 was not impaired ( Figure 6B ).
PLC-g1 activation is required for downstream activation of the NFAT and AP-1 transcription factors that participate in transcriptional activation of IL-2. Consistent with reduced PLC-g1 phosphorylation and calcium flux, cells expressing SLP-76 Y173F exhibited markedly reduced activation of an NFAT-luciferase reporter plasmid in response to TCR stimulation ( Figure 7A, left panel) . TCR-induced NFAT activation was impaired to a similar extent by three different mutations that disrupt Y173 ( Figure 7B , left panel), but as expected, none of the mutations disrupted NFAT activation in response to PMA and ionomycin, pharmacologic stimuli that bypass SLP-76 ( Figure 7B , right panel). These mutations disrupt tyrosine 173 in different ways: increasing hydrophobicity while preserving a similar structure (Y173F), not affecting hydrophobicity (Y173A), or deleting the entire region (D158-180). The similar effect of structurally different mutations suggests that impaired signalling results from the loss of phosphorylation at tyrosine 173, rather than from any regional effect on hydrophobicity or local structure. Activation of an AP-1 luciferase reporter plasmid was also reduced ( Figure 7A , middle panel). Most importantly, activation of a luciferase reporter construct driven by the IL-2 promoter was markedly reduced upon mutation of tyrosine 173 ( Figure 7A, right panel) . Together these results support the functional importance of this evolutionarily conserved tyrosine phosphorylation site.
Mast cell activation depends on tyrosine 173 of SLP-76
Functional studies in the J14 background are quite informative, but may not fully reflect the role of Y173 in untransformed, primary haematopoietic cells. Primary bone marrowderived mast cells (BMMCs) are a complementary system for addressing the signalling functions of SLP-76, since SLP-76 is required for their activation through the FceRI, but is not required for their development (Pivniouk et al, 1999) . To this end, we retrovirally reconstituted SLP-76-deficient or wildtype bone marrow with different alleles of SLP-76, followed by in vitro differentiation to the mast cell lineage and sorting for infected cells. We chose to compare the Y173F mutant of SLP-76 to the Y145F mutant, which exhibits dramatically reduced SLP-76 functionality in both T cells and mast cells (Jordan et al, 2006 (Jordan et al, , 2008 Lenox et al, 2009) .
On a biochemical level, both the Y173F and Y145F mutations markedly impaired FceRI-induced phosphorylation of PLC-g1 and p38 Map kinase ( Figure 8A ). As a measure of upstream processes, we looked at phosphorylation of SLP-76 itself at tyrosine 128, which was not diminished by the Y173 mutation ( Figure 8A , middle panels). Thus, it appears that in mast cells, as in the J14 model, Y173 is required to couple upstream events to the activation of PLC-g1.
In line with the reduction in PLC-g1 phosphorylation, FceRI-induced calcium flux was consistently reduced by the Y173F mutation, but was somewhat above the baseline level exhibited by SLP-76-deficient mast cells and cells expressing the Y145F mutation ( Figure 8B, left panel) . Thapsigargin- were transiently transfected with the indicated luciferase reporter plasmids along with a renilla luciferase plasmid for normalization purposes. After 16 h, the cells were mock stimulated (À) or stimulated for 6 h with plate-bound anti-TCR alone, or in combination with 10 mg/ml soluble a-CD28, as indicated in the graphs. Firefly luciferase activity was normalized to the renilla luciferase activity measured in the same well. Normalized values were expressed relative to the activity measured in TCR-stimulated wild-type cells from the same experiment. 'n' indicates the number of independent experiments averaged in each panel; error bars indicate the s.d. between independent experiments. The two-tailed Student's t-test was used to evaluate the statistical significance of differences in TCR-induced luciferase activity; '**' indicates a P-value of o0.005 for the indicated cell type as compared with wild-type cells. (B) J14 cells stably infected with the indicated alleles of SLP-76 were transiently transfected with an NFAT-luciferase reporter plasmid and renilla luciferase control plasmid. Luciferase activity was measured following 6 h of stimulation with plate-bound anti-TCR, or with PMA (50 ng/ml) and ionomycin (1 mM). Shown is the average normalized luciferase activity from three independent experiments, error bars indicating the s.d. '*' indicates a P-value of o0.02 for the indicated cell type as compared with wild-type cells.
induced calcium flux was also measured, to rule out differences in cell viability or calcium stores, and did not differ between the cell types ( Figure 8B , right panel). The effect on downstream calcium-dependent effector responses was consistent with the reduction in calcium flux. FceRI-induced degranulation was consistently reduced to a similar extent by the 173F and 145F mutations ( Figure 8C ). On a longer time scale, FceRI-induced secretion of IL-6 was markedly reduced by the Y173F mutation, although not to the same extent as the Y145F mutation ( Figure 8D ). Taken together, these experiments support the idea that Y173 of SLP-76 has an important regulatory role in antigen receptor signalling pathways, by coupling the early events of the pathway to activation of PLC-g1, thereby impacting PLC-g1-dependent downstream events.
Discussion
Current models depict two aspects of SLP-76 activation: its phosphorylation by ZAP-70 at three N-terminal sites, and its recruitment to LAT via Gads (Zou et al, 2010) . In this study, we uncover an additional layer of regulation, via tyrosine phosphorylation of SLP-76 at a fourth, evolutionarily conserved site, Y173. This site is inducibly phosphorylated upon TCR stimulation of primary murine or Jurkat T cells. Y173 phosphorylation occurs by a sequential mechanism that depends on prior phosphorylation of the three N-terminal sites. This is most easily understood in terms of the requirement of the N-terminal sites for TCR-induced recruitment and activation of Itk (Bogin et al, 2007) , along with the ability of Itk, but not ZAP-70 to phosphorylate Y173 in vitro. Most importantly, Y173 is required for antigen receptorinduced phosphorylation of PLC-g1, and for consequent, PLC-g1-dependent responses to antigen receptor stimulation. Our mast cell reconstitution experiments establish the importance of Y173 in the context of nontransformed, primary haematopoietic cells, and demonstrate its role in both short-and long-term responses to antigen, exemplified by degranulation and cytokine production, respectively. Surprisingly, mutation of Y173 produced a signalling defect comparable to mutation of Y145, a site of well-established importance in both T and mast cells (Jordan et al, 2006 (Jordan et al, , 2008 Lenox et al, 2009) .
SLP-76 exemplifies the reciprocal regulatory interactions that can occur between kinases and adaptor proteins. Upon TCR stimulation, SLP-76 binds and activates two protein kinases, Itk and HPK1 (Sauer et al, 2001; Bogin et al, 2007) . By virtue of their close interaction with SLP-76, these kinases are ideally situated to provide feedback by phosphorylating SLP-76 at one or more sites. Indeed, HPK1 phosphorylates SLP-76 at a negative regulatory site (Di Bartolo et al, 2007; Shui et al, 2007) , and we now show that Itk can exert positive feedback on SLP-76 by phosphorylating it at tyrosine 173. The sequential phosphorylation of SLP-76 by ZAP-70 and Itk may allow diverse regulatory inputs to modulate T-cell responsiveness. We speculate that at some developmental stages, decreased phosphorylation of Y173 may uncouple antigen receptor signalling from calcium-dependent effector functions, whereas at other developmental stages, increased Y173 phosphorylation could recouple these events. While entirely speculative, this hypothesis suggests potential implications of studying the multiple layers of regulation of SLP-76.
In intact cells, Y173 phosphorylation is not necessarily limited to Itk, but may be carried out by other Tec-family kinases, such as Rlk and Btk. Rlk is partially redundant with Itk for T-cell development and function (Schaeffer et al, 1999) , and was previously reported to phosphorylate SLP-76 (Schneider et al, 2000) , although the precise sites and their physiologic relevance were not mapped. Mast cell activation is regulated by both Itk and Btk (Iyer et al, 2011) , and it remains to be seen which kinase may phosphorylate Y173 in this cell type, and with what time course. The strong mast cell phenotype observed upon mutation of Y173 is consistent with the notion that it is phosphorylated upon FceRI stimulation; nonetheless, we have not yet observed its phosphorylation in this cell type. Btk function is better understood in B cells, where it binds to SLP-65 (Hashimoto et al, 1999; Su et al, 1999) , a B-cell adaptor analogous to SLP-76 (Fu et al, 1998; Wienands et al, 1998) . We note a conserved motif Y(V/I/A)DNR (Y138 in chicken SLP-65) that is inducibly phosphorylated upon BCR stimulation (Oellerich et al, 2009) , and roughly aligns by location and sequence with SLP-76 Y173. It will be interesting to see whether this motif has a regulatory role resembling Y173 in SLP-76.
Phosphorylation of Y173 was profoundly dependent on the three, previously characterized tyrosine phosphorylation sites, both in a J14-based model and in primary mouse thymoctes and splenocytes. Past studies have ascribed discrete functions to these sites, suggesting that Y112 and 128 bind to Nck and Vav, whereas Y145 binds to Itk (Raab et al, 1997; Fang and Koretzky, 1999; Wunderlich et al, 1999; Bunnell et al, 2000) . More recent studies suggest that Itk, Vav and Nck bind to SLP-76 in a cooperative, interdependent manner, probably due to the direct interaction of Vav with both Itk and Nck (Dombroski et al, 2005; Barda-Saad et al, 2010) . It therefore becomes difficult to clearly differentiate between Vav-and Itk-mediated signalling events; and indeed, analyses of the SLP-76 N-terminal tyrosine mutants in a mouse model revealed graded defects, where mutating SLP-76 Y112 and Y128 was somewhat less severe than mutating Y145 (Jordan et al, 2006 (Jordan et al, , 2008 Lenox et al, 2009) . Consistent with this notion, mutation of Y112 and 128 (Y2F) profoundly disrupted Y173 phosphorylation, as did mutation of Y145 alone. We therefore suggest that cooperative interactions at the N-terminus of SLP-76 create a signalling complex that is competent to phosphorylate the adjacent Y173.
The most prominent biochemical phenotype of T and mast cells observed upon mutation of SLP-76 at Y173 was reduced phosphorylation of PLC-g1 at Y783. In mast cells, reduced PLC-g1 phosphorylation was associated with dramatically reduced calcium flux and downstream effector functions. In contrast, calcium flux was moderately but persistently reduced in the J14 background, while DAG-dependent events such as Erk phosphorylation and CD69 expression were not appreciable reduced, suggesting that PLC-g1 activity was not completely abrogated. To some extent, calcium flux in this model may occur independently of PLC-g1 phosphorylation; indeed, tyrosine phosphorylation-independent mechanisms of PLC-g activation have been described (Sekiya et al, 1999a, b; Piechulek et al, 2005) , and PLC-g-independent mechanisms of TCR-induced calcium flux have been proposed (Matza et al, 2008) . One important aspect of PLC-g1 activation is its recruitment to the membrane, where its substrate is located. Constitutive recruitment of PLC-g1 to the membrane partially activates the enzyme (Veri et al, 2001) , although it can be further activated upon its phosphorylation at tyrosine 783 (Beach et al, 2006) . Vav and Cbl also contribute to PLC-g1 activation through incompletely understood mechanisms (Reynolds et al, 2002; Rellahan et al, 2003; Chiang et al, 2009; Saveliev et al, 2009) . Finally, PI-3-kinase activity, which is constitutively high in Jurkat-derived cell lines due to the absence of PTEN (Shan et al, 2000) , contributes to PLC-g1 membrane recruitment and activation. Most likely, constitutive activation of the PI-3-kinase pathway, together with intact recruitment of PLC-g1 and Vav to the SLP-76-nucleated complex may permit partial PLC-g1 activation and facilitate its interaction with membrane-bound substrates, despite a low level of PLC-g1 phosphorylation.
Our observations highlight the importance of subtle regulatory interactions that occur within the SLP-76-Gads-LATnucleated complex. Itk-mediated phosphorylation of PLC-g1 depends on a docking interaction between the kinase domain of Itk, and a basic surface on the back of the C-terminal SH2 domain of PLC-g1 (PLC-SH2C); in brief, Itk binds to PLC-SH2C, and this allows it to phosphorylate PLC-g1 at the adjacent Y783 (Joseph et al, 2007; Min et al, 2009) . The marked reduction in PLC-g1 phosphorylation upon mutation of SLP-76 Y173 suggests that it may participate in this docking event. This contribution cannot be viewed in terms of recruitment of signalling molecules to the complex, since mutation of Y173 did not reduce recruitment of Itk, Vav or PLC-g1 to the SLP-76-nucleated complex. The contribution of Y173 also does not involve activation of Itk, since its tyrosine phosphorylation and catalytic activity were not appreciably reduced upon mutation of SLP-76 Y173. We therefore suggest that phosphorylation of Y173 triggers conformational changes within the SLP-76-nucleated complex, that facilitate the interaction of SLP-76-bound, active Itk with its substrate, PLC-g1.
Y173 phosphorylation may trigger a conformational change in SLP-76 itself that brings the catalytic domain of Itk closer to its target sites in PLC-g1. This type of phosphorylation-induced conformation change occurs in ZAP-70, where phosphorylation of interdomain B tyrosines disrupts hydrophobic interactions and promotes a switch to the active conformation (Deindl et al, 2007) . Consistent with their structural role, mutation of interdomain B tyrosines to phenylalaine stabilizes the inactive conformation, whereas deletion or mutation to alanine reduces hyrophobicity and stabilizes the active conformation (Brdicka et al, 2005) . In contrast, SLP-76 function was disrupted to an equal extent by a Y173F mutation, Y173A mutation or deletion of the region surrounding Y173. These data are most consistent with a model in which phosphotyrosine 173 promotes SLP-76-mediated signalling by binding to an SH2 domain within a target protein.
Since mutation of Y173 profoundly affects PLC-g1 phosphorylation, we speculate that the target protein that binds to phospho-Y173 may be PLC-g1 itself. PLC-g1 has two SH2 domains followed by one SH3 domain. Whereas the N-terminal SH2 domain recruits PLC-g1 to LAT (Stoica et al, 1998) , we suggest that PLC-SH2C may bind to SLP-76 phospho-Y173. Consistent with this notion, mutation of the PLC-SH2C profoundly impairs TCR-induced phosphorylation of PLC-g1 at Y783, and abrogates its interaction with SLP-76 (Braiman et al, 2006) . In further support of this idea, we note that SLP-76 Y173 is found within a motif (MYIDR) that is somewhat homologous to PLC-g1 Y783 (FYVEA); this similarity may underlie the selective phosphorylation of both motifs by Itk (Bogin et al, 2007 and this study) . Although neither motif corresponds precisely to the optimal binding motif of PLC-SH2C (Songyang et al, 1993; Huang et al, 2008) , PLC-SH2C is known to undergo an intramolecular interaction with phosphoY783 (Poulin et al, 2005) , and we speculate that the similar motif at SLP-76 Y173 may likewise have affinity for this SH2 domain. Binding of PLC-SH2C and Itk to adjacent sites on SLP-76 (Y173 and Y145, respectively) may facilitate docking of Itk onto PLC-SH2C. The subsequent phosphorylation of PLC-g1 is associated with the above-mentioned intramolecular rearrangement, whereby PLC-SH2C binds to the adjacent phospho-Y783, thereby promoting a catalytically active conformation (Poulin et al, 2005) . This rearrangement would detach PLC-g1 from SLP-76, perhaps allowing for successive binding and activation of multiple PLC-g1 molecules by each SLP-76-nucleated complex. This model shows how sequential phosphorylation of SLP-76 at Y173 may trigger conformational changes within the SLP-76-nucleated complex that modify the interaction of Itk with its substrate and promote PLC-g1 activation.
Materials and methods
Antibodies
The monoclonal antibody C305 was used for anti-TCR stimulations of Jurkat-derived cell lines (Weiss and Stobo, 1984) . Monoclonal anti-FLAG epitope (M2) and monoclonal anti-dinitrophenol (anti-DNP, IgE isotype) were from Sigma. Polyclonal anti-PLC-g1 and anti-Vav were from Santa Cruz Biotechnology. Anti-phosphotyrosine (4G10) and anti-Nck were from Upstate Cell Signaling Solutions. Phosphospecific anti-PLC-g1 pY783 was from MBL International or Cell Signaling Technology. Polyclonal anti-Itk (BL12) (Tomlinson et al, 1999) and monoclonal anti-Lck (clone 1F6) were provided by Michael G Tomlinson and Joseph Bolen. Polyclonal anti-ZAP-70 (Qian et al, 1997) was provided by Dapeng Qian and Arthur Weiss. Polyclonal anti-human SLP-76 was previously described (Gonen et al, 2005) . Polyclonal antiphospho-p44/42 MAPK (Thr202/Tyr204), anti-p44/42 MAPK (Erk1/2), anti-p38 and rabbit monoclonal anti-phospho-p38 (Thr180/Tyr182) were from Cell Signaling Technology. Monoclonal anti-mouse SLP-76, anti-mouse CD3e-biotin (clone 145-2C11), antimouse CD4-biotin (clone GK1.5) and anti-human CD3-APC were from eBioscience. Polyclonal phosphospecific antibodies to human SLP-76 Y113 and Y145 were from Novus Biologicals. Mouse monoclonal antibody to human SLP-76 Y128 was from BD Pharmingen. PE-Cy5-conjugated anti-CD69 was from Serotec.
A polyclonal, affinity-purified antibody against SLP-76 phosphoY173 was prepared by Eurogentec. Briefly, a phospho-peptide NSNSMpYIDRPPSG, corresponding to amino acids 168-180 of human SLP-76 was conjugated to KLH, and used to immunize rabbits, followed by two steps of affinity chromatography, to remove antibodies that recognize the nonphosphorylated peptide and enrich for those that recognize the phosphorylated peptide. In some experiments, we supplemented the diluted antiserum with 5 mg/ml phosphotyrosine-conjugated BSA; this additive decreased background without blocking the sequence-specific recognition of phospho-Y173.
Plasmids
Transient transfections were performed by electroporation using the Gene Pulser (Bio-Rad Laboratories, Hercules, CA), at a setting of 234 V and 1000 mF, using a 0.4-cm cuvette. EcoVR-Blast, the ecotropic viral receptor cloned into pEF6/Myc-His A, was provided by Jeroen Roose. pEF-BOS-based plasmids encoding wild-type or Y to F mutated, FLAG-tagged SLP-76, were used for transient transfection (Fang et al, 1996) . Retroviral infections were performed using the pMIGR1 vector (Pear et al, 1998) into which N-terminally FLAG-tagged human SLP-76 alleles were subcloned upstream of an IRES-GFP cassette. pMIGR1-based plasmids encoding untagged wild-type or Y145F-mutated mouse SLP-76 were previously described (Jordan et al, 2006) . Point mutations of human and mouse SLP-76 at codon 173 were made using the QuikChange sitedirected mutagenesis kit (Stratagene). All mutant constructs were verified by sequencing the entire insert.
Cell lines and retroviral infections
The Jurkat-derived SLP-76-deficient cell line, J14, and J14-derived cell lines stably transfected with FLAG-tagged wild-type SLP-76 (J14-76-11) or with FLAG-tagged SLP-76 bearing tyrosine to phenylalanine mutations at tyrosines 113, 128 and 145 (J14-Y3F) were previously described (Yablonski et al, 1998 ). J14Eco.1 was created by stable transfection of J14 with EcoVR-Blast, followed by limiting dilution in 10 mg/ml blasticidin, and screening colonies for efficient infection with ecotropic retroviruses. Retroviral packaging was performed in 293T cells by calcium-phosphate-mediated cotransfection of pMIGR1-based retroviral plasmids along with the ecotropic packaging vectors, pVPack-GP and pVPack-Eco (Stratagene). Undiluted (high titer) or diluted (low titer) cell supernatants were used for infection of J14Eco.1 cells, followed by FACS sorting for GFP expression at 2 weeks following infection.
In vitro phosphorylation of recombinant proteins
All GST fusion proteins were expressed in Escherichia coli BL21 bacteria, using the pGEX-2TK bacterial expression vector (Amersham Pharmacia Biotech) and purified on glutathione-agarose beads (Sigma), followed by elution with free glutatione (Sambrook and Russel, 2001) . In vitro phosphorylation reactions using anti-Itk or anti-ZAP-70 immune complexes as the source of kinase activity were performed as described (Bogin et al, 2007) .
Cell stimulation and lysis J14 derivatives were stimulated with C305 and lysed as described (Bogin et al, 2007) .
Murine splenic T cells were purified by negative or positive selection using a Pan T-cell isolation kit or CD90.2 microbeads, respectively (Miltenyi Biotec). Washed, purified splenic T cells or total thymocytes were resuspended in Dulbecco's PBS and were stimulated at 371C with biotinylated anti-CD3, with or without biotinylated anti-CD4, that was pre-crosslinked with avidin, at a final concentration of 10 mg/ml of each biotinylated antibody. Lysis buffer contained 50 mM Tris pH 8, 1% nonidet P40, 100 mM NaCl, 10% glycerol, 50 mM NaF, 2 mM Na 3 VO 4 , 50mM b-glycerol phosphate, 0.5 mM CaCl 2 , 20 mM sodium pyrophosphate, 5 mM EDTA and 1 mM DTT, 2 mM PMSF and a 1:100 dilution of the Sigma protease inhibitor cocktail (P8340).
Luciferase assays
Luciferase assays were performed as described (Yablonski et al, 1998) , except that each luciferase reporter plasmid (20 mg of NFAT luciferase, 10 mg of AP-1 luciferase or 20 mg of IL-2 luciferase) was cotransfected with 5 mg of pRL-null, which drives constitutive expression of renilla luciferase (Promega). Following 6 h of stimulation, cells were lysed with passive lysis buffer (Promega) and activity was measured with the Dual Luciferase Kit (Promega).
Mass spectrometry TCR-stimulated J14-76-11 cells were lysed and SLP-76 was purified by immunoprecipitation with anti-FLAG, followed by elution with a triple FLAG peptide (Sigma). Phosphorylated peptides derived from SLP-76 were obtained after in-gel digestion with endoproteinase Asp-N and subsequent enrichment of the phosphopeptides with TiO2 exactly as described (Oellerich et al, 2009) . Enriched phosphopeptides were analysed by LC-coupled MSMS and searched against a database as described (Oellerich et al, 2009 ).
Retroviral transduction of BMMCs
Primary BMMCs expressing different alleles of SLP-76 were generated by infection of bone marrow from SLP-76-deficient (Clements et al, 1998) or wild-type mice with an IRES-GFP-marked retroviral vector (pMIGR) that was either empty or encoded for different alleles of murine SLP-76. Infection, in vitro differentiation into the mast cell lineage under the influence of IL-3 and SCF, and sorting for GFP-expressing cells were performed as previously described (Kambayashi et al, 2010) . Experiments were begun when the cells were 495% cKit þ , FcERI þ , as shown by FACS staining. The entire process was repeated three times with comparable results in all functional assays. Prior to functional assays, cells were washed in cytokine-free medium and incubated overnight in medium containing 10 ng/ml IL-3, but lacking SCF. Cells were sensitized by incubation with 0.5-1 mg/ml IgE (anti-DNP) for 2-12 h and were then washed and resuspended in Tyrode's buffer (Kambayashi et al, 2010) containing 0.5 mg/ml BSA. Stimulation was initiated by the addition of DNP-conjugated human serum albumin (DNP-HSA). FceRI-induced phosphorylation events, calcium flux, degranulation and IL-6 production were measured exactly as described (Kambayashi et al, 2010) .
Multiple Sequence Alignments
Multiple Sequence Alignments were prepared using ClustalW2 (Larkin et al, 2007) .
Supplementary data
Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
